Clinical Trial Update: ADAMTS13 in Thrombotic Thrombocytopenic Purpura

View source ↗

Summary

The clinical trial investigating ADAMTS13 for thrombotic thrombocytopenic purpura has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• ADAMTS13 (ADAMTS13)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Thrombotic Thrombocytopenic Purpura | Status: COMPLETED